-
From Our LabsHow to address the culture gap between academia and industry in biomedicineExperts call for significant changes to facilitate the discovery of new treatments.
From Our Labs -
From Our LabsGiraffes have high blood pressure. Why don’t they drop dead?A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
From Our Labs -
From Our LabsStopping free radicals at their sourceCompounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
From Our Labs -
From Our LabsFive things to look for in a scientific mentorFrom Our Labs -
From Our LabsHow I built a mini-gut with next to no biology trainingFrom Our Labs -
From Our LabsFixing what’s lost in translationFrom Our Labs -
From Our LabsLetters to my younger self: Female scientists share their wisdomAccomplished female scientists at Novartis share their wisdom born from difficult moments in life.
From Our Labs -
From Our LabsNurturing the life science ecosystemFrom Our Labs -
From Our LabsCancer spies find drug-beating covert cellsFrom Our Labs -
From Our LabsTurning up the heat on tumorsFrom Our Labs -
From Our LabsVision hackerMaking clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
From Our Labs -
From Our LabsChemical genetics: The sleuthing behind modern drug discoveryResearchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.
From Our Labs